Company Overview and News
13h seekingalpha - 1
The changes that are underway closely mirror the process that alcohol went through after prohibition ended in the 1920s: liquor regained social acceptance and the product proliferated.
STZ.B ACBFF ITYBF TLRY APH WEED RLLRF GWP SMG IMBBY SHOP RRL CRON SF SFN STZ CGC HEIA QBC MFC ACB 0945 JNJ CBD MFC APHQF SFB IMBBF CNNRF
Chicago, IL – October 15, 2018 - Stocks in this week’s article include: Manulife Financial Corporation (MFC - Free Report) , Jazz Pharmaceuticals plc (JAZZ - Free Report) , DaVita Inc. (DVA - Free Report) , American Axle & Manufacturing Holdings, Inc. (AXL - Free Report) and Huntsman Corp. (HUN - Free Report) .
WFCNP JAZZ AXL HUN VSH WFC MFC 0945 HEAR MFC
WallStars are distinguished by positive broker target price upsides. Top 10 Financial Services 'safer' dividend WallStars, MC, MFC, LM, DGICA, APO, WBK, IVZ, LAZ, and BGCP averaged 33.89% upsides 10/10/18.
AIY BGCP AINV APO APAM AB TCRX WBC ARCC GBDC BGCA LMHA WEBNF AIB WBK TCRD LMHB TCRZ TSLF OCSI ARU MFC 0945 WBC LAZ MFC DGICA DGICB LM IVZ
In the present volatile stock market, value analysis, is becoming more and more important. When analyzing value stocks, most investors use the P/E ratio to search for lucrative stocks, but there are other ratios that an investor can consider, like the price-to-sales ratio (P/S) and price-to-book (P/B) ratio. The P/S ratio is simply price divided by sales. One of the reasons P/S is a better choice is because it looks at sales rather than earnings like the price-to-earnings ratio.
JAZZ AXL ON MFC HUN 0945 MFC DVA
Heightened volatility has once again shaken the stock market badly and pushed all major indices deep in red to start the final quarter of 2018. The CBOE Volatility Index (VIX), also known as the fear gauge, jumped to more than 28, its highest level since Feb 12, 2018. This suggests that market fears have started to set in. The fear gauge tends to outperform when markets are falling or fear levels are high.
CCR ONEY DKL UFS HDV JSC GLPRU MFC 0945 GLP MFC JPP DHS
In the present volatile stock market, value analysis, is becoming more and more important. In value stock analysis, most investors use the P/E ratio to search for lucrative stocks but there are other ratios that an investor can consider like price-to-sales ratio (P/S) and price-to-book (P/B) ratio. The P/S ratio is simply price divided by sales. One of the reasons Price to Sales ratio is a better choice is because it looks at sales rather than earnings like the P/E ratio.
DUKH JAZZ AXL DUK ON MFC HUN 0945 MFC
2018-10-11 globenewswire - 1
MONTREAL, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Earth Alive Clean Technologies Inc. (CSE: EAC) (“Earth Alive” or the “Company”), is pleased to announce the nomination of Ann Catherine Barnes to its Board of Directors.
CRON BCB MFC 0945 COT MFC
2018-10-05 seekingalpha - 1
This is the third quarter review of my retirement income portfolio. It was a very active quarter that included a final pension rollover to my IRA. About half of the rollover funds have been deployed. Some existing positions were trimmed to take profit and to diversify. In recent weeks, I've written articles about the 19 new positions, so this review will be a brief summary.
TXN CNUTF XOM RDSB ENB OPRF RDSA FTS WMT BCE CSCO ABBV DUKH BAMGF SO UPS MAIN TYT KMB CMI ENB MFC RY 0945 BNS JNJ ITW RYDBF 7203 WPC SPG ABBV MSFT QCOM PFE CLX CDUAF BAMKF NNN SOJA TM ADP SKT EPD TD ETN BNS MSCA AAPL BIP RYDAF TD CSCOI BAM BEP CU VTR IBM RDS.B RY RDS.A TNTTF APLE O DUK FDX TOYOF MSCA.CL BLK HP PEP ADPVV FTS PPL MFC
October 4, 2018: Here are four stocks trading with heavy volume among 158 equities making new 52-week lows in Thursday’s session. On the NYSE decliners led advancers by about 3.94 to 1, and on the Nasdaq, decliners led advancers by about 3.37 to 1.
JD F MFC 0945 MFC SNAP
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
MFC 0945 MFC
2018-10-02 zacks - 6
Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. However, when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.
MFC 0945 MFC
In a July article, I explained my intention to use a final pension rollover to increase the number of individual equity holdings in my retirement income portfolio from 30 up to possibly 50, beginning with four companies described in that article: AbbVie (ABBV), Apple Hospitality REIT (APLE), Brookfield Infrastructure Partners (BIP) and Main Street Capital (MAIN). Since then, I've added 15 additional companies:
SLFPF UL UPS APLE SL MAIN DTK MFC MSCA.CL 0945 MSCA MFC BIP SLFPY
2018-10-01 - Asif
Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...
2018-09-25 - Asif
Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...